Mobile Health Cardiac Rehabilitation for Ischemia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist individuals with INOCA, a heart condition characterized by chest pain or other symptoms without blocked arteries, using mobile health technology (mHealth-CR). Participants will use a smartphone app and a wearable device to track their activity and receive weekly counseling, aiming to improve overall health and quality of life. The trial compares this new method to regular medical care. It seeks individuals diagnosed with INOCA who can move independently and are comfortable using a smartphone app. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance future care for INOCA patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this mobile health cardiac rehabilitation is safe for patients with ischemia?
Research has shown that mobile health technology, such as the mHealth-CR program, is generally safe for individuals with heart problems. A review of remote heart rehab programs found no increase in long-term risks for participants. Thus, using apps and wearable devices to track activity and heart rate is both easy and safe.
Another study on home-based heart rehab found it safe and effective for people with heart disease, improving health without adding risk.
Overall, these findings suggest that mHealth-CR is a safe choice for those considering joining this trial.12345Why are researchers excited about this trial?
Researchers are excited about Mobile Health Cardiac Rehabilitation (mHealth-CR) because it revolutionizes cardiac rehab for ischemia by integrating technology into patient care. Unlike traditional cardiac rehabilitation, which typically involves in-person sessions, mHealth-CR leverages a smartphone app and wearable devices like a Fitbit or Apple Watch to track activity and heart rate, making it convenient and accessible. This method allows for daily therapist-directed activities and weekly phone support, providing personalized care from the comfort of home. By combining technology with rehabilitation, mHealth-CR aims to improve patient engagement and outcomes in managing ischemic heart conditions.
What evidence suggests that mHealth-CR is effective for cardiac rehabilitation in patients with INOCA?
Research has shown that mobile health tools for cardiac rehabilitation (mHealth-CR), which participants in this trial may receive, can help people with heart conditions improve their health. Some studies suggest that mobile apps for cardiac rehab can simplify tracking physical activity and keep patients engaged. These apps often include features like goal setting and automatic exercise tracking, which have been linked to better health outcomes. However, other studies found that mHealth-CR might not significantly enhance exercise ability or improve some health measures compared to regular care. While results are mixed, mHealth-CR has the potential to increase patient involvement and make rehab services more accessible.24678
Who Is on the Research Team?
Harmony Reynolds, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for individuals with INOCA, which means they have symptoms of heart issues but no blocked arteries. They must be part of the NYU Langone Health or Emory University Medical Center system and willing to use a wearable device and communicate with an exercise therapist for 3 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive mHealth-CR intervention including activity tracking, weekly counseling, and exercise documentation for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, with evaluations at 6 months and 1 year
What Are the Treatments Tested in This Trial?
Interventions
- mHealth-CR
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator